Iron overload is a hidden threat for many people living with blood disorders such as thalassemia, sickle cell anemia, or myelodysplastic syndromes. Repeated blood transfusions save lives — but over time, the excess iron they bring can damage vital organs. That’s where Deferasirox 500 mg tablets, marketed under the brand DEFROSIA 500, come in.

This guide explains what Deferasirox is, how it works, who needs it, the correct way to take it, possible side effects, and essential safety tips every patient should know.

Introduction to Iron Overload

Iron is an essential mineral needed to form hemoglobin and transport oxygen. However, our bodies have no natural mechanism to eliminate excess iron. When iron levels build up — typically after multiple transfusions — it begins to accumulate in the liver, heart, and other organs.

This condition is called chronic iron overload or secondary hemochromatosis.

If left untreated, toxic iron buildup may lead to serious complications such as:

• Liver fibrosis or cirrhosis
• Heart failure or arrhythmias
• Endocrine problems (e.g., diabetes or delayed puberty)
• Fatigue and organ dysfunction

Managing iron overload early is crucial.

What Is DEFROSIA 500 (Deferasirox 500 mg)?

DEFROSIA 500 is a brand of Deferasirox Dispersible Tablets 500 mg, an oral medication designed to chelate (bind and remove) excess iron from the body. It belongs to a class of drugs known as iron chelators.

Unlike older chelators that required injections, Deferasirox offers a convenient once‑daily oral therapy, helping patients maintain long‑term treatment with better comfort and compliance.

Composition of DEFROSIA 500

Each DEFROSIA 500 tablet contains:

• Active ingredient: Deferasirox 500 mg
• Dosage form: Dispersible tablet (to be dissolved in water before taking)
• Excipients: Pharmaceutically approved substances that aid tablet formulation and dispersion

How Does Deferasirox Work?

Iron in the body exists in a stored form bound to ferritin and hemosiderin. Deferasirox binds to free and loosely bound iron molecules, forming a stable Deferasirox‑iron complex.

This complex is excreted from the body through the bile and feces, effectively reducing total body iron stores.

To simplify:

1. Chelation: Deferasirox attaches to excess iron in the blood.
2. Neutralization: It neutralizes iron’s toxic oxidative effects.
3. Elimination: The iron‑drug bond is eliminated naturally via stool.

Indications: When Is DEFROSIA 500 Prescribed?

DEFROSIA 500 (Deferasirox 500 mg) is indicated to treat chronic iron overload due to:

• Frequent blood transfusions (transfusional hemosiderosis)
• Non‑transfusion–dependent thalassemia (NTDT), when iron accumulates due to increased absorption from the gut

Your doctor may recommend DEFROSIA 500 if:

• You have thalassemia major or intermedia and receive regular transfusions
• You have sickle cell anemia or aplastic anemia
• You show high serum ferritin or elevated liver‑iron concentration levels

Who Should Not Take DEFROSIA 500?

DEFROSIA 500 is not suitable for everyone. It should not be used in individuals who:

• Have known hypersensitivity to Deferasirox or any component of the tablet
• Have severe kidney impairment or eGFR < 40 mL/min/1.73 m²
• Have severe liver disease
• Have ongoing severe gastrointestinal bleeding or ulcers
• Are pregnant or breastfeeding, unless specifically advised by a doctor

Always inform your healthcare provider about all medical conditions and medications you take before starting DEFROSIA 500.

Dosage and Administration

1. Typical Dose

The dosage depends on your body weight, age, and degree of iron overload (usually measured by serum ferritin).

• Initial dose: Around 20 mg/kg body weight per day for transfusion‑related iron overload.
• Adjustment: The doctor may increase or decrease the dose by 5–10 mg/kg monthly based on ferritin trends.
• Maximum dose: Typically not above 40 mg/kg/day.

2. How to Take DEFROSIA 500

• Always take it once daily on an empty stomach, at least 30 minutes before food.
• Do not swallow whole.
• Disperse the tablet completely in a glass of water, orange juice, or apple juice (about 100–200 mL).
• Stir and drink immediately.
• Rinse the glass with a bit more liquid and drink to ensure the full dose is consumed.

3. Missed Dose

• Take the missed dose as soon as remembered the same day.
• If the next dose is near, skip the missed one — do not double up.

Monitoring Treatment

Iron chelation therapy requires regular monitoring. During DEFROSIA 500 treatment, your doctor will periodically check:

• Serum ferritin levels (monthly or as advised)
• Liver function tests (ALT, AST, bilirubin)
• Kidney function (creatinine, urinary protein)
• Complete blood counts

These tests help ensure your treatment is safe and effective, and the dosage remains optimal.

Benefits of DEFROSIA 500 (Deferasirox 500 mg)

• Convenient once‑daily dose — easy to maintain long‑term therapy
• Dispersible formulation — ideal for children and adults who have difficulty swallowing tablets
• Effective iron removal — clinically proven to reduce ferritin and liver‑iron concentration
• Improved organ protection — supports healthier heart and liver function over time
• Enhanced quality of life — oral therapy avoids painful injections

Possible Side Effects

Like all medications, DEFROSIA 500 can cause side effects in some patients. Most are mild to moderate and manageable.

Common side effects:

• Nausea or vomiting
• Abdominal pain
• Diarrhea
• Headache
• Skin rash

Less common but serious side effects:

• Increased serum creatinine (kidney dysfunction)
• Elevation of liver enzymes
• Hearing or vision changes
• Gastrointestinal bleeding or ulcer

If you experience persistent vomiting, dark urine, yellowing eyes, swelling, or visual/hearing problems, stop the medication and contact your doctor immediately.

Drug Interactions

Deferasirox can interact with several other medicines. Inform your physician if you are taking:

• Antacids containing aluminum
• Cyclosporine or Tacrolimus (may raise kidney risk)
• NSAIDs (e.g., Ibuprofen, Naproxen — risk of GI bleeding)
• Corticosteroids
• Oral bisphosphonates
• Warfarin or other anticoagulants

Avoid alcohol or non‑prescribed supplements during therapy unless cleared by your doctor.

Pregnancy and Breastfeeding

Deferasirox is classified as pregnancy risk category D — it may harm an unborn baby.

• During pregnancy: Use only if the potential benefit clearly outweighs the risk.
• During breastfeeding: It is generally not recommended, as it may pass into breast milk.

Women of childbearing age should discuss effective contraception while on DEFROSIA 500.

Storage and Handling

• Store DEFROSIA 500 tablets at room temperature (below 30°C).
• Keep them in the original blister pack to protect from moisture.
• Keep out of reach of children.
• Do not use expired or damaged tablets.

Special Instructions

• Never share your medication with others, even if symptoms appear similar.
• Continue therapy regularly unless advised otherwise — interruption can reverse progress.
• Maintain a healthy diet and avoid unnecessary iron supplements or high‑iron foods, unless a nutritionist directs otherwise.
• Drink plenty of fluids daily to support kidney function.

What to Expect During Treatment

At first, patients might not “feel” immediate changes, as the benefit lies in preventing organ damage long‑term. With regular use and consistent monitoring, ferritin levels start declining over several months.

Symptoms of improvement:

• Stabilized or improved liver function
• Increased energy over time
• Delay or prevention of iron‑induced organ complications

Patience and adherence are key — iron removal is gradual, not instant.

Clinical Evidence and Research

Clinical studies have proven that Deferasirox reduces serum ferritin and liver‑iron concentration (LIC) significantly, protecting long‑term organ function.

• In multi‑center trials, equivalent iron reduction was achieved compared to deferoxamine with much better adherence.
• Over 5‑year follow‑up, patients showed maintained ferritin reduction and improved cardiac T2* MRI readings.
• Deferasirox is endorsed by guidelines from WHO and Thalassemia International Federation as a standard oral chelator.

Lifestyle Tips for Patients on DEFROSIA 500

Managing iron overload goes beyond medication:

1. Stay Hydrated: Drink 2–3 liters of water daily unless restricted.
2. Eat wisely: Limit high‑iron foods such as liver, red meat, and fortified cereals.
3. Avoid vitamin C supplements unless prescribed; they can increase iron absorption.
4. Track your ferritin results — keep a personal logbook.
5. Exercise moderately to maintain general fitness and organ function.

A holistic approach makes chelation more effective.

When to Contact Your Doctor

Seek medical attention promptly if you notice:

• Swelling of the face, lips, or throat (allergic reaction)
• Unusual bruising or bleeding
• Black/tarry stools
• Decrease in urine output
• Severe abdominal or back pain
• Vision or hearing changes

These may indicate rare but serious side effects needing immediate care.

DEFROSIA 500: Key Product Highlights

• Generic name: Deferasirox 500 mg
• Form: Dispersible oral tablets
• Class: Oral iron chelator
• Manufacturer brand: DEFROSIA
• Purpose: Treatment of chronic iron overload
• Prescription required: Yes

Summary

DEFROSIA 500 (Deferasirox 500 mg) is a modern, convenient, once‑daily oral therapy that helps remove excess iron in patients receiving regular transfusions.

Through effective chelation, it protects the heart, liver, and other organs from iron‑induced damage. When used responsibly under medical supervision, DEFROSIA 500 greatly enhances both longevity and quality of life for patients living with transfusion‑dependent blood disorders.

Continue treatment exactly as prescribed, stay consistent with check‑ups, and maintain a healthy lifestyle — these habits make all the difference in long‑term success.

Frequently Asked Questions

1. Is DEFROSIA 500 safe for children?
Yes — Deferasirox is approved for children aged 2 years and older with transfusional iron overload, under strict medical supervision.

2. How long will I need to take DEFROSIA 500?
Chelation therapy is typically long‑term, often continuing as long as blood transfusions are needed. Your doctor will decide based on ferritin levels.

3. Can I take DEFROSIA 500 with food?
It should be taken on an empty stomach for best absorption — 30 minutes before food.

4. What if I vomit after taking it?
If vomiting occurs within 30 minutes, take another dose. If later than that, skip and continue as scheduled next day.

5. Does DEFROSIA 500 cure thalassemia?
No. It doesn’t treat the underlying disease — it controls iron overload, a major complication of transfusions.